IL10 and colitis: To further define the role of NF-κB signalling in the development of C.jejuni-induced colitis, NF-κB activation was pharmacologically inhibited in gnotobiotic IL-10−/−; NF-κBEGFP mice using Bay 11-7085 (200 μg/kg i.p.; 3 injections per week for 14 days).